DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Bioanalytical Testing Services Market 2021-2031 by Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

Asia Pacific bioanalytical testing services market will grow by 11.2% annually with a total addressable market cap of $13,359.1 million over 2022-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Five Forces

Based on Molecule Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Small Molecules
• Large Molecules
• LC-MS Studies
• Immunoassays
• Other Large Molecule Tests

Based Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Bioavailability and Bioequivalence Studies
• Pharmacokinetics (PK)
• Pharmacodynamics (PD)
• Absorption, Distribution, Metabolism, Excretion (ADME)
• Other Applications

By Test Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Cell-based Assays
• Bacterial Cell-based Assays
• Viral Cell-based Assays
• Virology Testing
• In Vitro Virology Testing
• In Vivo Virology Testing
• Species-Specific Viral PCR Assays
• Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
• Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
• Viral Serology, Immunogenicity, and Neutralizing Antibodies
• Method Development Optimization and Validation (MDOV)
• Biomarker Testing
• Pharmacokinetic Testing
• Other Test Types

By Workflow Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Sample Preparation
• Protein Precipitation
• Liquid-liquid Extraction (LLE)
• Sample Analysis
• Hyphenated Technique
• Chromatographic Technique
• Electrophoresis
• Ligand Binding Assay
• Mass Spectrometry
• Nuclear Magnetic Resonance
• Other Workflow Processes

By Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Therapeutic Areas

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

• Pharma and Biopharma Companies
• Contract Development and Manufacturing Organizations (CDMOs)
• Contract Research Organizations (CROs)�

Selected Key Players:

• Charles River Laboratories International Inc.
• Covance Inc.
• Eurofins Scientific
• ICON PLC
• Intertek Group PLC
• IQVIA Holdings, Inc.
• Laboratory Corporation of America Holdings
• Medpace Holdings, Inc.
• Pace Analytical Services LLC.
• Parexel International Corporation
• PPD Inc.
• SGS SA
• Syneos Health, LLC
• Toxikon Corporation
• WuXi Apptech Co., Ltd.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

3 Segmentation of Asia Pacific Market by Molecule Type

4 Segmentation of Asia Pacific Market by Application

5 Segmentation of Asia Pacific Market by Test Type

6 Segmentation of Asia Pacific Market by Workflow Process

7 Segmentation of Asia Pacific Market by Therapeutic Area

8 Segmentation of Asia Pacific Market by End User

9 Asia-Pacific Market 2021-2031 by Country

10 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/xxq5rt

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900